https://www.sciencedaily.com/news/health_medicine/pharmaceuticals/ Research news on the pharmaceutical industry including new drugs and interventions. en-us Fri, 10 Jul 2026 08:30:16 EDT Fri, 10 Jul 2026 08:30:16 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/health_medicine/pharmaceuticals/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/07/260709160655.htm A naturally occurring bacterium from amphibian intestines completely eliminated colorectal tumors in mice with a single treatment by both attacking cancer cells and activating the immune system. The findings point to a promising new type of cancer therapy that could one day work against many solid tumors. Fri, 10 Jul 2026 00:13:15 EDT https://www.sciencedaily.com/releases/2026/07/260709160655.htm https://www.sciencedaily.com/releases/2026/07/260708022204.htm Poison control calls involving semaglutide (Ozempic and Wegovy) soared after the drug was approved for weight management, with researchers linking the increase to accidental dosing mistakes rather than intentional misuse. Simple education about proper weekly dosing and gradual dose increases could help prevent many of these avoidable incidents. Thu, 09 Jul 2026 00:02:10 EDT https://www.sciencedaily.com/releases/2026/07/260708022204.htm https://www.sciencedaily.com/releases/2026/07/260708022158.htm Tiny silica nanoparticles engineered to seek out prostate cancer caused tumor cells to self-destruct and supercharged the immune system in preclinical mouse studies. Combined with immunotherapy, the treatment produced complete remissions in multiple mice, raising hopes for a powerful new approach to prostate cancer. Wed, 08 Jul 2026 22:18:49 EDT https://www.sciencedaily.com/releases/2026/07/260708022158.htm https://www.sciencedaily.com/releases/2026/07/260707054111.htm A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements for people with type 2 diabetes than the leading oral semaglutide in a major clinical trial. The tablet could offer a more convenient alternative to injectable drugs like Ozempic and Wegovy because it doesn't require refrigeration or special timing with meals. It's also cheaper to manufacture, which could expand access globally. Tue, 07 Jul 2026 05:41:11 EDT https://www.sciencedaily.com/releases/2026/07/260707054111.htm https://www.sciencedaily.com/releases/2026/07/260701205001.htm Researchers have cracked the code behind bacteria's ability to naturally manufacture multiple versions of powerful anti-cancer drugs. The discovery could make it much easier to engineer new cancer treatments inspired by nature, including improved versions of existing medicines. Wed, 08 Jul 2026 17:28:31 EDT https://www.sciencedaily.com/releases/2026/07/260701205001.htm https://www.sciencedaily.com/releases/2026/07/260701015237.htm Scientists have discovered that creatine may strengthen one of the immune system's most important cancer-fighting pathways by energizing dendritic cells that activate killer T cells. The promising results could eventually help make immunotherapy more effective, but they have not yet been tested in human patients. Wed, 08 Jul 2026 05:32:21 EDT https://www.sciencedaily.com/releases/2026/07/260701015237.htm https://www.sciencedaily.com/releases/2026/06/260626030430.htm A UCLA study has identified a hidden Achilles' heel in aggressive small cell cancers that have resisted new treatments for decades. Scientists found that tumors lacking the RB gene become critically dependent on the protein E2F3 for survival. Blocking E2F3 shut down tumor growth in laboratory models, and existing FDA-approved drugs may be able to exploit this vulnerability. The discovery could pave the way for faster development of more effective therapies. Sat, 04 Jul 2026 15:26:54 EDT https://www.sciencedaily.com/releases/2026/06/260626030430.htm https://www.sciencedaily.com/releases/2026/06/260623014014.htm Researchers found that a rare liver cancer evades immunotherapy by luring immune T cells away from the tumor and trapping them in nearby fibrous tissue. An FDA-approved drug called AMD3100 freed those T cells to attack the cancer, significantly improving the effectiveness of immunotherapy in tumor samples. Thu, 25 Jun 2026 10:38:45 EDT https://www.sciencedaily.com/releases/2026/06/260623014014.htm https://www.sciencedaily.com/releases/2026/06/260623014006.htm A massive national study found that nearly half of Americans with kidney failure who are referred for a transplant never even begin the evaluation process, and only 19% make it onto the transplant waitlist. Researchers discovered that factors such as where a person lives, whether they are married, their income level, language, age, and even which transplant center they use can dramatically affect their chances of moving forward. Wed, 01 Jul 2026 16:10:45 EDT https://www.sciencedaily.com/releases/2026/06/260623014006.htm https://www.sciencedaily.com/releases/2026/06/260620100434.htm Researchers found that highly drug-resistant bacteria from hospitals are also resistant to glyphosate, a commonly used weedkiller. The discovery suggests that agricultural herbicides may be helping antibiotic-resistant microbes survive and spread far beyond healthcare settings. Tue, 23 Jun 2026 07:31:51 EDT https://www.sciencedaily.com/releases/2026/06/260620100434.htm https://www.sciencedaily.com/releases/2026/06/260620100317.htm A new stem-cell-inspired technique allows scientists to grow vast numbers of immune-cell progenitors that can be engineered to hunt cancer and strengthen immune responses. In animal studies, the cells fought tumors, restored immune function, and showed promise as a durable, off-the-shelf therapy platform. Mon, 29 Jun 2026 16:58:56 EDT https://www.sciencedaily.com/releases/2026/06/260620100317.htm https://www.sciencedaily.com/releases/2026/06/260619101400.htm A new intranasal DNA vaccine may give the immune system an extra weapon against tuberculosis by targeting bacteria that can hide from antibiotics. In animal studies, it helped clear infections faster, reduced lung inflammation, and prevented relapse after treatment. The vaccine also enhanced the performance of drugs used against drug-resistant TB. Sat, 04 Jul 2026 04:54:49 EDT https://www.sciencedaily.com/releases/2026/06/260619101400.htm https://www.sciencedaily.com/releases/2026/06/260619101345.htm Researchers discovered an “Achilles’ heel” shared by E. coli, Shigella, and other diarrhea-causing bacteria: enzymes they use to breach the gut’s protective mucus layer. By targeting this common vulnerability, scientists may be able to develop a single vaccine that prevents several major diarrheal infections before they even begin. Sun, 05 Jul 2026 22:16:38 EDT https://www.sciencedaily.com/releases/2026/06/260619101345.htm https://www.sciencedaily.com/releases/2026/06/260614011850.htm A new oral GLP-1 medication helped people with type 2 diabetes dramatically improve blood sugar control and lose weight in a major clinical trial. The results suggest that highly effective diabetes treatments may soon become available in a much more convenient pill form. Mon, 15 Jun 2026 05:45:59 EDT https://www.sciencedaily.com/releases/2026/06/260614011850.htm https://www.sciencedaily.com/releases/2026/06/260612021604.htm A new treatment that blocks an aging-related protein restored lost cartilage in old mice and helped prevent arthritis after knee injuries. Human cartilage samples showed similar signs of regeneration, raising hopes for a future drug that could repair joints instead of replacing them. Fri, 12 Jun 2026 08:35:15 EDT https://www.sciencedaily.com/releases/2026/06/260612021604.htm https://www.sciencedaily.com/releases/2026/06/260608040023.htm The largest review ever conducted on opioids for acute pain found that these widely prescribed drugs often deliver only small, short-lived benefits. For many common conditions, including some surgeries and kidney stone pain, opioids performed no better than a placebo. Researchers also found higher rates of side effects and warned that dependence can begin after only a short period of use. Tue, 09 Jun 2026 02:44:51 EDT https://www.sciencedaily.com/releases/2026/06/260608040023.htm https://www.sciencedaily.com/releases/2026/06/260605023417.htm Scientists have identified genetic variants that may make some people less responsive to GLP-1 drugs used to treat Type 2 diabetes. Roughly 10% of the population carries these variants, which appear to cause a mysterious form of "GLP-1 resistance." In several clinical trials, carriers were significantly less likely to reach healthy blood sugar targets while taking GLP-1 medications. Fri, 05 Jun 2026 11:13:02 EDT https://www.sciencedaily.com/releases/2026/06/260605023417.htm https://www.sciencedaily.com/releases/2026/06/260605023408.htm Supplements are often marketed as shortcuts to better health, but for many older adults, the real issue is whether they have a specific deficiency. Vitamins like B12 and D can play an important role when levels are low, while protein may be one of the most overlooked nutrients for maintaining strength and independence. More isn’t always better, though—some supplements can cause harm or interact with medications. Sat, 06 Jun 2026 08:40:28 EDT https://www.sciencedaily.com/releases/2026/06/260605023408.htm https://www.sciencedaily.com/releases/2026/06/260604044247.htm For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic tumors—something many scientists once thought couldn't be done. In a major clinical trial, the treatment nearly doubled survival for patients with advanced disease and reduced the risk of death by 60%. Thu, 04 Jun 2026 09:18:44 EDT https://www.sciencedaily.com/releases/2026/06/260604044247.htm https://www.sciencedaily.com/releases/2026/06/260603015541.htm Scientists have developed an experimental diabetes and obesity pill that works in a completely different way from drugs like Ozempic. Rather than reducing hunger, it activates metabolism in skeletal muscle, helping lower blood sugar and increase fat burning while preserving muscle mass. Early clinical results suggest the treatment is safe and well tolerated. Wed, 03 Jun 2026 09:27:40 EDT https://www.sciencedaily.com/releases/2026/06/260603015541.htm https://www.sciencedaily.com/releases/2026/06/260601025352.htm A long-overlooked organ may hold surprising clues to healthy aging and cancer survival. Researchers at Mass General Brigham used AI to analyze CT scans from tens of thousands of adults and found that people with healthier thymuses—a small immune-system organ once thought to become largely irrelevant after childhood—lived longer and had substantially lower risks of heart disease, cancer, and death. Mon, 01 Jun 2026 06:17:04 EDT https://www.sciencedaily.com/releases/2026/06/260601025352.htm https://www.sciencedaily.com/releases/2026/05/260530004626.htm A new study suggests fish oil may help reduce insulin resistance even in people who aren't obese. In diabetic rats, omega-3 supplementation improved blood sugar levels, cholesterol, and inflammation by shifting immune cells into a more anti-inflammatory mode. Sun, 31 May 2026 01:15:13 EDT https://www.sciencedaily.com/releases/2026/05/260530004626.htm https://www.sciencedaily.com/releases/2026/05/260529043644.htm A specially formulated tomato-soy juice packed with natural plant compounds may help calm inflammation linked to obesity, according to a new clinical study. Healthy adults with obesity who drank the juice daily for four weeks saw significant reductions in several key inflammatory proteins in their blood, while a control tomato juice did not produce the same effect. Sat, 30 May 2026 01:53:49 EDT https://www.sciencedaily.com/releases/2026/05/260529043644.htm https://www.sciencedaily.com/releases/2026/05/260527023204.htm A surprising new approach to depression treatment is showing early promise — not by targeting brain chemicals, but by calming the immune system. In a small clinical trial, researchers found that an anti-inflammatory drug normally used for rheumatoid arthritis appeared to ease symptoms in people with hard-to-treat depression, while also reducing fatigue and anxiety and improving quality of life. Thu, 28 May 2026 00:42:54 EDT https://www.sciencedaily.com/releases/2026/05/260527023204.htm https://www.sciencedaily.com/releases/2026/05/260527023200.htm Researchers found that drinking guava juice may significantly improve anemia by helping the body absorb iron more efficiently. In a review of 17 studies, women and teenage girls who consumed guava juice — especially with iron supplements — experienced noticeable increases in hemoglobin levels. Since guava contains far more vitamin C than oranges, scientists believe it could become a simple, affordable nutrition tool in regions where anemia is widespread. Wed, 27 May 2026 03:09:36 EDT https://www.sciencedaily.com/releases/2026/05/260527023200.htm https://www.sciencedaily.com/releases/2026/05/260524021154.htm Drinking nitrate-rich beetroot juice may do more than support heart health — it could actually reshape the bacteria living in the mouth in ways that help lower blood pressure in older adults. In the largest study of its kind, researchers found that older people who drank concentrated beetroot juice twice daily for two weeks experienced noticeable blood pressure reductions, while younger adults did not. Mon, 25 May 2026 01:01:09 EDT https://www.sciencedaily.com/releases/2026/05/260524021154.htm https://www.sciencedaily.com/releases/2026/05/260523103914.htm By analyzing over 400,000 Reddit posts, researchers discovered that users of popular GLP-1 weight-loss drugs frequently discussed unexpected symptoms like menstrual irregularities, chills, and hot flashes. The findings suggest AI could turn social media into a powerful early-warning system for spotting side effects that clinical trials may miss. Sun, 24 May 2026 07:30:31 EDT https://www.sciencedaily.com/releases/2026/05/260523103914.htm https://www.sciencedaily.com/releases/2026/05/260522023308.htm Scientists have created an AI-powered system that can scan and map an entire mouse body in extraordinary detail — and it just uncovered a surprising new effect of obesity. Beyond disrupting metabolism, obesity appears to damage facial sensory nerves linked to touch and sensation, while also triggering widespread inflammation across the body. Sat, 23 May 2026 08:34:45 EDT https://www.sciencedaily.com/releases/2026/05/260522023308.htm https://www.sciencedaily.com/releases/2026/05/260522023134.htm A new analysis is raising concerns about Wegovy, the blockbuster weight-loss drug, after researchers found it may carry the highest risk of a rare “eye stroke” that can cause sudden vision loss. The study, based on millions of FDA side-effect reports, found the risk signal was nearly five times stronger for Wegovy than for Ozempic, despite both containing semaglutide. Sat, 23 May 2026 09:23:30 EDT https://www.sciencedaily.com/releases/2026/05/260522023134.htm https://www.sciencedaily.com/releases/2026/05/260521072408.htm Researchers have discovered that the GLP-1 hormone targeted by drugs like Wegovy is present in very low amounts inside the joints of arthritis patients. That finding suggests high-dose GLP-1 medications could potentially reach the joints and influence inflammation directly, not just help through weight loss. Scientists say this could open the door to a completely new approach to arthritis treatment. Fri, 22 May 2026 02:12:43 EDT https://www.sciencedaily.com/releases/2026/05/260521072408.htm https://www.sciencedaily.com/releases/2026/05/260510234654.htm A major new analysis suggests semaglutide (Ozempic, Wegovy) works remarkably well in adults over 65, helping many lose substantial amounts of weight while improving heart and metabolic health. Participants taking the drug lost over 15% of their body weight on average — far more than those receiving placebo treatment. Many also moved out of obesity categories entirely and reached healthier weight levels. Mon, 11 May 2026 00:57:51 EDT https://www.sciencedaily.com/releases/2026/05/260510234654.htm https://www.sciencedaily.com/releases/2026/05/260506225217.htm A little-known tree from Brazil’s Atlantic Forest may hold a surprising weapon against COVID-19. Researchers discovered that compounds called galloylquinic acids, extracted from its leaves, can attack SARS-CoV-2 on multiple fronts—blocking the virus from entering cells, disrupting its replication, and even dampening harmful inflammation. Unlike many antivirals that target just one part of the virus, these natural compounds act in several ways at once, potentially making it harder for resistance to develop. Thu, 07 May 2026 21:39:59 EDT https://www.sciencedaily.com/releases/2026/05/260506225217.htm https://www.sciencedaily.com/releases/2026/05/260505234618.htm A short burst of immunotherapy before surgery is delivering surprisingly powerful results for a specific type of colorectal cancer. Patients in a UK-led trial who received just nine weeks of pembrolizumab prior to surgery have remained cancer-free nearly three years later—an outcome that challenges the standard approach of surgery followed by months of chemotherapy. Wed, 06 May 2026 02:20:17 EDT https://www.sciencedaily.com/releases/2026/05/260505234618.htm https://www.sciencedaily.com/releases/2026/04/260427050620.htm Researchers have found an enzyme that can turn fragile drug molecules into durable ring shapes. This could help medications like Ozempic last longer and work more effectively. The process is simpler and more precise than traditional methods, even for complex drugs. It may open the door to stronger, longer-lasting treatments. Tue, 28 Apr 2026 00:11:44 EDT https://www.sciencedaily.com/releases/2026/04/260427050620.htm https://www.sciencedaily.com/releases/2026/04/260422044630.htm A newly discovered virus hiding inside a common gut bacterium could help explain one of medicine’s long-standing mysteries: why a microbe found in both healthy people and cancer patients is linked to colorectal cancer. The research suggests that the interaction between bacteria and the viruses they carry may be key to understanding disease risk. It may even lead to future screening tests that detect cancer risk earlier. Wed, 22 Apr 2026 09:02:43 EDT https://www.sciencedaily.com/releases/2026/04/260422044630.htm https://www.sciencedaily.com/releases/2026/04/260422003024.htm Scientists have discovered that combining two existing drugs can dramatically reduce liver fat linked to a common and often silent disease. The treatment not only improved liver health in animal models but also showed potential to lower heart-related risks. Interestingly, using lower doses of both drugs together worked just as well as higher doses alone. While promising, the findings still need to be tested in humans. Wed, 22 Apr 2026 00:51:12 EDT https://www.sciencedaily.com/releases/2026/04/260422003024.htm https://www.sciencedaily.com/releases/2026/04/260420014738.htm A popular Korean skincare ingredient may be far more powerful than anyone realized. Scientists have discovered that madecassic acid—derived from the herb Centella asiatica—can stop antibiotic-resistant bacteria in their tracks, including dangerous strains of E. coli. By targeting a bacterial protein that humans don’t have, the compound disrupts the microbes’ ability to survive, making it a promising new type of antibiotic. Tue, 21 Apr 2026 01:33:16 EDT https://www.sciencedaily.com/releases/2026/04/260420014738.htm https://www.sciencedaily.com/releases/2026/04/260417224454.htm A surprising new study suggests that eating a very healthy diet—packed with fruits, vegetables, and whole grains—might be linked to a higher risk of lung cancer in younger non-smokers. Researchers found that patients under 50 diagnosed with lung cancer often had better-than-average diets, raising the possibility that pesticide exposure from conventionally grown produce could be a hidden culprit. Fri, 17 Apr 2026 23:27:27 EDT https://www.sciencedaily.com/releases/2026/04/260417224454.htm https://www.sciencedaily.com/releases/2026/04/260416071953.htm Scientists have uncovered a surprising twist in how bacteria share genes—including those that spread antibiotic resistance. Tiny virus-like particles called gene transfer agents (GTAs), once ancient viral invaders, have been repurposed by bacteria into delivery systems that shuttle DNA between neighboring cells. The study reveals a key control hub of three genes, dubbed LypABC, that triggers bacterial cells to burst open and release these DNA-packed couriers. Fri, 17 Apr 2026 07:44:05 EDT https://www.sciencedaily.com/releases/2026/04/260416071953.htm https://www.sciencedaily.com/releases/2026/04/260413043141.htm Scientists have developed a new way to fight gum disease without wiping out the mouth’s helpful bacteria—a major shift from traditional treatments. Instead of killing everything, this targeted approach blocks only the harmful microbes that drive periodontitis, allowing beneficial bacteria to thrive and restore balance naturally. Mon, 13 Apr 2026 10:02:46 EDT https://www.sciencedaily.com/releases/2026/04/260413043141.htm https://www.sciencedaily.com/releases/2026/04/260413043138.htm Public restrooms might seem like a germ nightmare, but the real risks aren’t always where you think. While toilet seats can carry bacteria, viruses, and even parasite traces, studies show they’re often cleaner than high-touch surfaces like door handles and flush levers. The biggest hidden threat comes from “toilet plumes”—tiny germ-filled droplets launched into the air when flushing without a lid—and from poor hand hygiene. Mon, 13 Apr 2026 04:31:38 EDT https://www.sciencedaily.com/releases/2026/04/260413043138.htm https://www.sciencedaily.com/releases/2026/04/260411022029.htm A new study reveals that popular diabetes and weight-loss drugs like Ozempic and Wegovy may not work as effectively for about 10% of people due to specific genetic variants. These individuals appear to have a puzzling condition called “GLP-1 resistance,” where their bodies produce higher levels of the hormone targeted by these drugs—but don’t respond to it properly. Sun, 12 Apr 2026 08:58:54 EDT https://www.sciencedaily.com/releases/2026/04/260411022029.htm https://www.sciencedaily.com/releases/2026/04/260410083114.htm A common eye-health nutrient, zeaxanthin, may also help the body fight cancer more effectively. Scientists discovered it strengthens T cells and enhances the impact of immunotherapy treatments. Found in everyday vegetables and supplements, it’s safe, accessible, and shows strong potential as a cancer therapy booster. Human trials are the next step. Fri, 10 Apr 2026 09:55:45 EDT https://www.sciencedaily.com/releases/2026/04/260410083114.htm https://www.sciencedaily.com/releases/2026/04/260408225950.htm Chronic inflammation often works quietly in the background but can fuel serious diseases like diabetes, heart disease, and cancer. New research reveals that everyday plant compounds—like menthol from mint, cineole from eucalyptus, and capsaicin from chili peppers—can team up inside immune cells to dramatically boost their anti-inflammatory power. While individual compounds showed modest effects, certain combinations amplified results hundreds of times over by activating different cellular pathways at once. Thu, 09 Apr 2026 02:57:22 EDT https://www.sciencedaily.com/releases/2026/04/260408225950.htm https://www.sciencedaily.com/releases/2026/04/260406192907.htm A surprising new study reveals that what you eat could play a powerful role in fighting cholera, a deadly diarrheal disease. Researchers found that diets rich in certain proteins—especially casein from dairy and wheat gluten—can dramatically reduce the ability of cholera bacteria to take hold in the gut, in some cases cutting infection levels by up to 100 times. These proteins appear to disable a key “weapon” the bacteria use to attack other microbes and dominate the gut environment. Tue, 07 Apr 2026 03:22:01 EDT https://www.sciencedaily.com/releases/2026/04/260406192907.htm https://www.sciencedaily.com/releases/2026/04/260403224458.htm Scientists have created an artificial saliva using a sugarcane protein that can protect teeth and fight bacteria. The key ingredient, CANECPI-5, binds directly to enamel, forming a shield against acids that cause decay. Early tests show it works even better when paired with fluoride and xylitol, significantly reducing damage to teeth. The innovation could be especially life-changing for cancer patients who lose saliva production after treatment. Sun, 05 Apr 2026 00:38:05 EDT https://www.sciencedaily.com/releases/2026/04/260403224458.htm https://www.sciencedaily.com/releases/2026/04/260402042744.htm Scientists have created a programmable drug system that can zero in on cancer cells with unprecedented accuracy. Built from synthetic DNA, it only activates when it detects a precise combination of tumor markers, preventing damage to healthy tissue. The system can also deliver multiple drugs at once, potentially overcoming resistance. This marks a step toward medicines that behave more like smart, responsive machines inside the body. Thu, 02 Apr 2026 04:27:44 EDT https://www.sciencedaily.com/releases/2026/04/260402042744.htm https://www.sciencedaily.com/releases/2026/03/260331001054.htm A breakthrough urine test could dramatically speed up how doctors treat urinary tract infections, identifying the right antibiotic in under six hours instead of waiting days. By testing directly from urine—skipping the usual lab culturing step—the method quickly shows which drugs stop bacterial growth and which don’t. In trials involving hundreds of patient samples, the test proved highly accurate, matching standard methods in over 96% of cases. Tue, 31 Mar 2026 01:45:05 EDT https://www.sciencedaily.com/releases/2026/03/260331001054.htm https://www.sciencedaily.com/releases/2026/03/260330001129.htm A powerful cholesterol-lowering drug may be changing the rules of heart disease prevention. Researchers found that evolocumab, typically used for people who already have cardiovascular disease, can significantly cut the risk of first-time heart attacks and strokes in high-risk patients with diabetes—even before any artery-clogging plaque is detected. Mon, 30 Mar 2026 03:29:23 EDT https://www.sciencedaily.com/releases/2026/03/260330001129.htm https://www.sciencedaily.com/releases/2026/03/260326080752.htm Gut bacteria aren’t just passive passengers—they can actively send proteins straight into our cells. Using microscopic injection systems, even harmless microbes can influence immune responses and metabolic pathways. Researchers found these interactions may play a role in inflammatory diseases like Crohn’s. It’s a major shift in how scientists understand the microbiome’s power over human health. Fri, 27 Mar 2026 08:23:14 EDT https://www.sciencedaily.com/releases/2026/03/260326080752.htm https://www.sciencedaily.com/releases/2026/03/260321012659.htm A new pill, enlicitide, reduced LDL (“bad”) cholesterol by about 60% in a large clinical trial, matching the power of injectable therapies. Because it’s taken orally, it could overcome one of the biggest barriers keeping patients from using current treatments. Researchers say many people still don’t reach safe cholesterol levels—even on statins—highlighting the need for better options. Sat, 21 Mar 2026 08:04:04 EDT https://www.sciencedaily.com/releases/2026/03/260321012659.htm https://www.sciencedaily.com/releases/2026/03/260321012638.htm Antibiotics are accumulating in a major Brazilian river, especially during the dry season when pollution becomes more concentrated. Scientists even detected a banned drug inside fish sold for food, raising concerns about human exposure. A common aquatic plant showed promise in removing these chemicals from water—but it also altered how fish absorb them, creating unexpected risks. Sat, 21 Mar 2026 20:48:07 EDT https://www.sciencedaily.com/releases/2026/03/260321012638.htm https://www.sciencedaily.com/releases/2026/03/260318033111.htm Malaria parasites contain tiny spinning crystals that have puzzled scientists for years. New research reveals they’re powered by a rocket-like reaction that breaks down hydrogen peroxide, releasing energy. This motion may help the parasite detoxify harmful chemicals and manage iron more efficiently. The discovery could lead to new drugs and spark innovations in microscopic robotics. Thu, 19 Mar 2026 07:19:27 EDT https://www.sciencedaily.com/releases/2026/03/260318033111.htm https://www.sciencedaily.com/releases/2026/03/260315225121.htm A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how it’s delivered—injecting it directly into tumors instead of into the bloodstream. In a small clinical trial of 12 patients with metastatic cancers, six saw their tumors shrink and two experienced complete remission. Mon, 16 Mar 2026 20:18:42 EDT https://www.sciencedaily.com/releases/2026/03/260315225121.htm https://www.sciencedaily.com/releases/2026/03/260315004403.htm Scientists at MIT have discovered that a little-known protein called intelectin-2 plays a powerful double role in defending the gut. The protein strengthens the mucus layer that lines the gastrointestinal tract while also trapping and disabling harmful bacteria that try to break through. By binding to sugars on both mucus molecules and bacterial surfaces, intelectin-2 forms a protective barrier and can even destroy microbes, including some that resist antibiotics. Mon, 16 Mar 2026 00:05:04 EDT https://www.sciencedaily.com/releases/2026/03/260315004403.htm https://www.sciencedaily.com/releases/2026/03/260313062539.htm Cambridge scientists have discovered a light-powered chemical reaction that lets researchers modify complex drug molecules at the final stages of development. Unlike traditional methods that rely on toxic chemicals and harsh conditions, the new approach uses an LED lamp to create essential carbon–carbon bonds under mild conditions. This could make drug discovery faster and more environmentally friendly. The breakthrough was uncovered unexpectedly during a failed laboratory experiment. Sat, 14 Mar 2026 01:56:59 EDT https://www.sciencedaily.com/releases/2026/03/260313062539.htm https://www.sciencedaily.com/releases/2026/03/260311004824.htm A newly developed antibiotic called EVG7 could offer a powerful new way to stop Clostridioides difficile, a dangerous gut bacterium that often returns after treatment. In mouse studies, researchers found that even a very small dose of EVG7 was highly effective at clearing the infection and preventing it from coming back. Unlike many current antibiotics, which wipe out large portions of the gut microbiome, EVG7 appears to spare beneficial bacteria that naturally help keep C. difficile in check. Wed, 11 Mar 2026 20:19:45 EDT https://www.sciencedaily.com/releases/2026/03/260311004824.htm https://www.sciencedaily.com/releases/2026/03/260307213244.htm A massive UK study of more than 165,000 dementia patients has uncovered troubling new evidence about risperidone, a commonly used drug for severe agitation. Researchers found the antipsychotic increases stroke risk in dementia patients across the board—including those with no prior heart disease or stroke—challenging the long-held belief that some patients might be safer candidates than others. Because risperidone is the only drug of its type licensed for dementia, doctors often use it as a last resort when distressing symptoms become unmanageable. Sun, 08 Mar 2026 16:45:01 EDT https://www.sciencedaily.com/releases/2026/03/260307213244.htm https://www.sciencedaily.com/releases/2026/03/260304184221.htm Scientists have uncovered a crucial weakness in the malaria parasite that could open the door to new treatments. Researchers identified a protein called Aurora-related kinase 1 (ARK1) that acts like a traffic controller during the parasite’s unusual cell division process, ensuring its genetic material is properly separated as it multiplies. When scientists switched off ARK1 in laboratory experiments, the parasite could no longer replicate correctly and failed to complete its life cycle in both humans and mosquitoes—effectively halting its ability to spread. Thu, 05 Mar 2026 00:03:04 EST https://www.sciencedaily.com/releases/2026/03/260304184221.htm https://www.sciencedaily.com/releases/2026/02/260228082723.htm Drug-resistant bacteria are becoming harder to treat, pushing scientists to look for new antibiotic targets. Researchers have now discovered that several unrelated viruses disable a key bacterial protein called MurJ, which is essential for building the bacterial cell wall. High-resolution imaging shows these viral proteins lock MurJ into a single position, stopping cell wall construction and leading to bacterial death. Sat, 28 Feb 2026 09:20:04 EST https://www.sciencedaily.com/releases/2026/02/260228082723.htm